Nasal COVID-19 Vaccine Based on WashU Technology to Enter U.S. Clinical Trials
A nasal vaccine for COVID-19 鈥 based on technology developed at Washington University in St. Louis 鈥 is poised to enter a phase 1 clinical trial in the U.S.
5-Feb-2025 7:00 PM EST
Add to Favorites